FDA director: The agency expects to approve Pfizer's vaccine after today's crucial hearing
- An expert panel is meeting today to advise the
FDAon whether to approve or deny Pfizer's coronavirus vaccinefor emergency use.
- Before it began, FDA Commissioner
Stephen Hahntold NBC's Savannah Guthrie the vaccinealready meets the agency criteria for approval, but that it will still take into account what the panel recommends.
- After the panel's vote, Hahn said, the FDA plans to "act quickly."
- Follow Business Insider's live blog of the hearing today.
A panel of independent experts is meeting today to evaluate Pfizer's
But FDA Commissioner Dr. Stephen Hahn said the outcome is already predictable, and that the agency intends to act on the advisory panel's advice immediately.
"We'll have to see what the scientific and medical discussion is today. But our plan is to take their recommendations into account for our decision making and make a decision shortly thereafter ... We intend to act quickly," he told Savannah Guthrie live on NBC News' TODAY before the advisory committee convened.
The head of the FDA assured, "our initial assessment is that this is a vaccine that does meet our criteria … But we do want to hear from the vaccine advisory committee."
If indeed approved, high-priority Americans, including nursing home residents and
Pfizer's vaccine has been shown to be safe and 95% effective at preventing symptomatic COVID-19. But the advisory committee will likely discuss the pros and cons of approving a vaccine that still has a lot of unknowns, like whether it protects against asymptomatic infection and "silent spreading," how long its protection against COVID-19 lasts, and whether there's enough data on older Americans to justify injecting some of them first.
- Apricots: A nutrient-packed fruit for health and culinary delights
- Startup funding hits a 5-year low in July-September quarter
- Mobile phone exports from India cross Rs 45,000 cr in April-Aug period, Apple leads
- Twinkle, Akshay pose with UK PM Rishi Sunak in London
- Troubles mount for Indian airlines, even in good times